Mercer Island, WA, United States of America

John E Bergmann

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Mercer Island, WA (US) (2010 - 2015)
  • Albany, CA (US) (2015 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of John E. Bergmann

Introduction

John E. Bergmann is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods and diagnostic tools. With a total of 6 patents, his work has had a profound impact on the understanding and treatment of various diseases.

Latest Patents

Among his latest patents, Bergmann has developed innovative solutions such as the G protein coupled receptor 85 and SREB3 knockout mice and uses thereof. This invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, along with methods for their production. These polypeptides and polynucleotides are instrumental in diagnosing and treating diseases and disorders. Additionally, he has created methods for identifying compounds, such as agonists or antagonists, using the GPCR polypeptides and polynucleotides, which can be used to treat conditions associated with GPCR dysfunction. Another significant patent involves the use of PDE7 inhibitors for treating movement disorders, including Parkinson's disease and Restless Leg Syndrome. This method involves administering a therapeutically effective amount of a PDE7 inhibitory agent, potentially in conjunction with a dopamine agonist or precursor.

Career Highlights

Bergmann is currently associated with Omeros Corporation, where he continues to advance his research and innovations. His work has been pivotal in developing new therapeutic strategies that address complex neurological conditions.

Collaborations

Throughout his career, Bergmann has collaborated with esteemed colleagues, including Hongkui Zeng and Neil S. Cutshall. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

John E. Bergmann's contributions to biotechnology through his patents and innovative research have significantly advanced the field. His work continues to inspire and pave the way for new therapeutic approaches to complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…